I know what your problem is
You're two stents!
I have the sinking feeling (maybe it should be "clotting") that the bare-metal vs. drug-eluting stents debate* is going to be our decade's version of dietary epidemiology: small effects, multiple studies, uncertain conclusions of doubtful clinical relevance. (For example, the latest NEJM-published meta-analysis looks at a four-year follow-up. I really hope our patients with stents live longer than that.)
*Short version: Vessels in which bare-metal stents are inserted tend nevertheless to fail (close off again) after a short time. Stents which elute drugs avoid this first problem but have recently been associated with an increased risk of thrombosis (clotting). Of course, whether these first two statements are true is also open to question . . .